What does Xenetic Biosciences, Inc. do?

Jun 22 2025 06:50 PM IST
share
Share Via
Xenetic Biosciences, Inc. is a biopharmaceutical company specializing in personalized CAR T technology for targeting tumor neoantigens, with a market cap of $4.30 million. As of March 2025, it reported net sales of $1 million and a net loss of $1 million.
Overview:
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on developing personalized chimeric antigen receptor (CAR) T platform technology for targeting patient-specific tumor neoantigens in the Pharmaceuticals & Biotechnology industry, with a market cap in the micro-cap bracket.

Financial Snapshot:
Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)
Market cap: USD 4.30 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.01
Return on Equity: -57.85%
Price to Book: 0.84

Contact Details:
Address: 40 Speen St Ste 102, FRAMINGHAM MA: 01701-1898
Tel: 1 781 7787720
Website: https://www.xeneticbio.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Xenetic Biosciences, Inc. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via